v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues        
Revenues $ 2,852 $ 2,530 $ 5,376 $ 4,789
Expenses        
Selling, general and administrative 907 894 1,768 1,761
Research and development 173 159 336 302
Amortization of intangible assets 225 256 466 512
Goodwill impairments 0 0 1,426 0
Restructuring, integration and separation costs 9 31 22 32
Other expense (income), net 26 (18) 58 (3)
Total expenses 2,112 2,086 5,586 4,069
Operating income (loss) 740 444 (210) 720
Interest income 11 13 21 24
Interest expense (396) (465) (798) (795)
Gain (loss) on extinguishment of debt 0 178 (1) 178
Foreign exchange and other (7) (30) (18) (34)
Income (loss) before income taxes 348 140 (1,006) 93
Provision for income taxes (88) (12) (165) (51)
Net income (loss) 260 128 (1,171) 42
Net (income) loss attributable to noncontrolling interest (2) 20 6 48
Net income (loss) attributable to Bausch Health Companies Inc. $ 258 $ 148 $ (1,165) $ 90
Earnings (loss) per share attributable to Bausch Health Companies Inc.        
Basic loss per share attributable to Bausch Health Companies Inc. (in usd per share) $ 0.69 $ 0.40 $ (3.12) $ 0.24
Diluted loss per share attributable to Bausch Health Companies Inc. (in usd per share) $ 0.68 $ 0.40 $ (3.12) $ 0.24
Weighted-average common shares        
Basic weighted-average common shares (in shares) 375.0 370.9 373.9 370.3
Diluted weighted-average common shares (in shares) 378.1 373.1 373.9 373.5
Product sales        
Revenues        
Revenues $ 2,825 $ 2,504 $ 5,325 $ 4,731
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues 753 748 1,474 1,431
Other revenues        
Revenues        
Revenues 27 26 51 58
Expenses        
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues $ 19 $ 16 $ 36 $ 34